OPKO Health PE Ratio 2010-2025 | OPK
Current and historical p/e ratio for OPKO Health (OPK) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OPKO Health PE ratio as of June 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OPKO Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-20 | 1.29 | 0.00 | |
| 2025-03-31 | 1.66 | $-0.07 | 0.00 |
| 2024-12-31 | 1.47 | $-0.09 | 0.00 |
| 2024-09-30 | 1.49 | $-0.19 | 0.00 |
| 2024-06-30 | 1.25 | $-0.33 | 0.00 |
| 2024-03-31 | 1.20 | $-0.35 | 0.00 |
| 2023-12-31 | 1.51 | $-0.25 | 0.00 |
| 2023-09-30 | 1.60 | $-0.27 | 0.00 |
| 2023-06-30 | 2.17 | $-0.27 | 0.00 |
| 2023-03-31 | 1.46 | $-0.38 | 0.00 |
| 2022-12-31 | 1.25 | $-0.44 | 0.00 |
| 2022-09-30 | 1.89 | $-0.44 | 0.00 |
| 2022-06-30 | 2.53 | $-0.29 | 0.00 |
| 2022-03-31 | 3.44 | $-0.18 | 0.00 |
| 2021-12-31 | 4.81 | $-0.05 | 0.00 |
| 2021-09-30 | 3.65 | $0.11 | 33.18 |
| 2021-06-30 | 4.05 | $0.11 | 36.82 |
| 2021-03-31 | 4.29 | $0.19 | 22.58 |
| 2020-12-31 | 3.95 | $0.05 | 79.00 |
| 2020-09-30 | 3.69 | $-0.18 | 0.00 |
| 2020-06-30 | 3.41 | $-0.33 | 0.00 |
| 2020-03-31 | 1.34 | $-0.48 | 0.00 |
| 2019-12-31 | 1.47 | $-0.53 | 0.00 |
| 2019-09-30 | 2.09 | $-0.48 | 0.00 |
| 2019-06-30 | 2.44 | $-0.42 | 0.00 |
| 2019-03-31 | 2.61 | $-0.33 | 0.00 |
| 2018-12-31 | 3.01 | $-0.27 | 0.00 |
| 2018-09-30 | 3.46 | $-0.52 | 0.00 |
| 2018-06-30 | 4.70 | $-0.55 | 0.00 |
| 2018-03-31 | 3.17 | $-0.58 | 0.00 |
| 2017-12-31 | 4.90 | $-0.56 | 0.00 |
| 2017-09-30 | 6.86 | $-0.22 | 0.00 |
| 2017-06-30 | 6.58 | $-0.17 | 0.00 |
| 2017-03-31 | 8.00 | $-0.11 | 0.00 |
| 2016-12-31 | 9.30 | $-0.07 | 0.00 |
| 2016-09-30 | 10.59 | $-0.03 | 0.00 |
| 2016-06-30 | 9.34 | $0.25 | 37.36 |
| 2016-03-31 | 10.39 | $0.14 | 74.21 |
| 2015-12-31 | 10.05 | $-0.10 | 0.00 |
| 2015-09-30 | 8.41 | $-0.22 | 0.00 |
| 2015-06-30 | 16.08 | $-0.58 | 0.00 |
| 2015-03-31 | 14.17 | $-0.55 | 0.00 |
| 2014-12-31 | 9.99 | $-0.40 | 0.00 |
| 2014-09-30 | 8.51 | $-0.32 | 0.00 |
| 2014-06-30 | 8.84 | $-0.38 | 0.00 |
| 2014-03-31 | 9.32 | $-0.33 | 0.00 |
| 2013-12-31 | 8.44 | $-0.33 | 0.00 |
| 2013-09-30 | 8.81 | $-0.29 | 0.00 |
| 2013-06-30 | 7.10 | $-0.15 | 0.00 |
| 2013-03-31 | 7.63 | $-0.18 | 0.00 |
| 2012-12-31 | 4.81 | $-0.10 | 0.00 |
| 2012-09-30 | 4.18 | $-0.04 | 0.00 |
| 2012-06-30 | 4.60 | $-0.04 | 0.00 |
| 2012-03-31 | 4.73 | $-0.02 | 0.00 |
| 2011-12-31 | 4.90 | $-0.01 | 0.00 |
| 2011-09-30 | 4.33 | $-0.08 | 0.00 |
| 2011-06-30 | 3.69 | $-0.08 | 0.00 |
| 2011-03-31 | 3.73 | $-0.09 | 0.00 |
| 2010-12-31 | 3.67 | $-0.09 | 0.00 |
| 2010-09-30 | 2.24 | $-0.12 | 0.00 |
| 2010-06-30 | 2.26 | $-0.09 | 0.00 |
| 2010-03-31 | 1.98 | $-0.09 | 0.00 |
| 2009-12-31 | 1.83 | $-0.12 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.023B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.564B | 79.96 |
| Thermo Fisher Scientific (TMO) | United States | $150.197B | 18.17 |
| Edwards Lifesciences (EW) | United States | $43.309B | 28.40 |
| IDEXX Laboratories (IDXX) | United States | $42.135B | 48.42 |
| Alcon (ALC) | Switzerland | $42.123B | 28.47 |
| DexCom (DXCM) | United States | $31.369B | 48.49 |
| IQVIA Holdings (IQV) | United States | $26.768B | 14.99 |
| Mettler-Toledo (MTD) | United States | $23.982B | 28.52 |
| STERIS (STE) | Ireland | $23.183B | 25.53 |
| Waters (WAT) | United States | $20.390B | 28.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.638B | 0.00 |
| Hologic (HOLX) | United States | $14.369B | 15.61 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $9.948B | 78.08 |
| Masimo (MASI) | United States | $8.956B | 33.04 |
| Globus Medical (GMED) | United States | $7.834B | 18.67 |
| Glaukos (GKOS) | United States | $5.723B | 0.00 |
| Teleflex (TFX) | United States | $5.228B | 8.63 |
| TransMedics (TMDX) | United States | $4.179B | 90.85 |
| Integer Holdings (ITGR) | United States | $4.110B | 21.54 |
| PROCEPT BioRobotics (PRCT) | United States | $3.332B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.481B | 14.78 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.067B | 29.00 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.292B | 121.00 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.901B | 4.79 |
| Beta Bionics (BBNX) | United States | $0.776B | 0.00 |
| IRadimed (IRMD) | United States | $0.741B | 37.57 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.553B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.523B | 12.25 |
| OrthoPediatrics (KIDS) | United States | $0.493B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.482B | 0.00 |
| AxoGen (AXGN) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.405B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.403B | 10.72 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.347B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.04 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.204B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.063B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |